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Abstract
Background: Digital innovations continue to shape health and health care. As technology socially integrates into daily living,
the lives of health care consumers are transformed into a key source of health information, commonly referred to as patient-generated
health data (PGHD). With chronic disease prevalence signaling the need for a refocus on primary prevention, electronic PGHD
might be essential in strengthening proactive and person-centered health care.
Objective: This study aimed to review and synthesize the existing literature on the utilization and implications of electronic
PGHD for primary disease prevention and health promotion purposes.
Methods: Guided by a well-accepted methodological framework for scoping studies, we screened MEDLINE, CINAHL,
PsycINFO, Scopus, Web of Science, EMBASE, and IEEE Digital Library. We hand-searched 5 electronic journals and 4 gray
literature sources, additionally conducted Web searches, reviewed relevant Web pages, manually screened reference lists, and
consulted authors. Screening was based on predefined eligibility criteria. Data extraction and synthesis were guided by an adapted
PGHD-flow framework. Beyond initial quantitative synthesis, we reported narratively, following an iterative thematic approach.
Raw data were coded, thematically clustered, and mapped, allowing for the identification of patterns.
Results: Of 183 eligible studies, targeting knowledge and self-awareness, behavior change, healthy environments, and remote
monitoring, most literature (125/183, 68.3%) addressed weight reduction, either through physical activity or nutrition, applying
a range of electronic tools from socially integrated to full medical devices. Participants generated their data actively (100/183,
54.6%), in combination with passive sensor-based trackers (63/183, 34.4%) or entirely passively (20/183, 10.9%). The proportions
of active and passive data generation varied strongly across prevention areas. Most studies (172/183, 93.9%) combined electronic
PGHD with reflective, process guiding, motivational and educational elements, highlighting the role of PGHD in multicomponent
digital prevention approaches. Most of these interventions (110/183, 60.1%) were fully automatized, underlining broader trends
toward low-resource and efficiency-driven care. Only a fraction (47/183, 25.6%) of studies provided indications on the impact
of PGHD on prevention-relevant outcomes, suggesting overall positive trends, especially on vitals (eg, blood pressure) and body
composition measures (eg, body mass index). In contrast, the impact of PGHD on health equity remained largely unexplored.
Finally, our analysis identified a list of barriers and facilitators clustered around data collection and use, technical and design
considerations, ethics, user characteristics, and intervention context and content, aiming to guide future PGHD research.
Conclusions: The large, heterogeneous volume of the PGHD literature underlines the topic’s emerging nature. Utilizing electronic
PGHD to prevent diseases and promote health is a complex matter owing to mostly being integrated within automatized and
multicomponent interventions. This underlines trends toward stronger digitalization and weaker provider involvement. A PGHD
use that is sensitive to identified barriers, facilitators, consumer roles, and equity considerations is needed to ensure effectiveness.
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Introduction
Background
The emergence of digital health innovations is expected to
continue shaping the organization and delivery of health services
[1,2]. As technology integrates into multiple domains of daily
living, its potential for disrupting health systems and societal
impact rapidly expands [1,3]. On an individual level, the uptake
of smart and wearable technology pushes the boundaries of
self-quantification and generates novel opportunities to monitor
and promote health [2,4]. These developments gradually
transform the lives of health care consumers into key health
information sources. The output is commonly referred to as
patient-generated health data (PGHD) [5].
Electronic and Patient-Generated Health Data
A landmark whitepaper by the US Office of the National
Coordinator for Health Information Technology defines PGHD
as health-related information created by patients or their
designees outside traditional health care contexts [6]. The current
emergence of PGHD can be partially attributed to 2 dominant
digitalization trends: the societal integration of mobile phones
and the growing health-related use of Web-based media [7-9].
Preinstalled mobile phone applications and integrated sensors
enable the continuous measurement of physical, mental, social,
and environmental health parameters, whereas online platforms
and social media increasingly become a place for health
communication and depositories of large data volumes [7,8,10].
These trends gradually transform consumers from passive
recipients to active agents of their health [1]. Acknowledging
the wide social integration of mobile devices, the generation of
one’s own health information might be a potential way to engage
medically underserved populations and close long-lasting
inequity gaps [11].
Digital and Proactive Prevention
As the prevalence of chronic diseases continues to rise, many
health care systems face unprecedented challenges that deem
it necessary to refocus on prevention [12]. Without disregarding
the challenges of electronic PGHD, generating one’s own health
information might provide an incentive for behavioral change,
facilitating health literacy and knowledge exchange [13,14].
Data sharing can in turn trigger personalized feedback,
customized health plans, and tailored persuasive health
promotion techniques [14,15]. In other words, PGHD can
contribute to proactive, informed, and prevention-focused health
systems, as well as personalized and collaborative care [16-18].
Despite those benefits, systematically and comprehensively
synthesized knowledge on the use of such data for primary
disease prevention and health promotion purposes seems to be
lacking.
Objectives
Our overarching objective targets the synthesis of the literature
on the overall utilization of electronic PGHD for primary disease
prevention and health promotion purposes. Specific objectives
include (1) providing an overview of applied PGHD types and
tools, as well as their aims, purposes, and contexts, (2) exploring
health care consumer, provider, and technology responsibilities,
as well as potential interactions among them, and (3)
synthesizing broader implications of electronic PGHD on health
outcomes and equity.
Methods
Methodological Framework
Overview
Our methodology was guided by Arksey and O’Malley’s
framework for scoping studies and Levac, Colquhoun, and
O’Brien’s conceptual extensions [19,20]. We divided our
approach accordingly into 6 steps, described separately in the
following sections. Study quality and evidence strength
assessment fall beyond the aims of a scoping review and were
not performed [19]. A detailed description of our methodological
and conceptual background has been published elsewhere [21].
Protocol deviations and their justifications are provided in
Multimedia Appendix 1.
Step 1: Identifying the Research Question
Our research question was formed by an iterative process by
getting acquainted with the literature, identifying existing
evidence gaps, as well as by regular exchange and expert
consultation. Our question consisted of the 3 previously
mentioned study objectives across the underlying dimensions
of (1) data generation and collection, (2) sharing or
communication, (3) interpretation, and (4) utilization. We
narrowed the definition of electronic PGHD to data generated
by consumer-facing means, excluding information that was
collected through standardized, provider-driven methods, such
as predefined questionnaires [22], which is justified on the very
nature of primary disease prevention and health promotion that
ideally requires an active patient. Similarly, we used the term
health care consumer, instead of patient, as our target population
consists of individuals free of any International Classification
of Disease–coded conditions. Nonetheless, we kept the patient
in PGHD, as that is an already coined term. The term provider
is conceptualized as any professional who is responsible for
offering health and well-being–related services.
Step 2: Identifying Relevant Studies
With the support of a specialized librarian and preliminary
literature review, we developed an extensive and purposively
sensitive search strategy, applied to 7 electronic databases that
included MEDLINE, Cumulative Index to Nursing and Allied
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Health Literature, PsycInfo, Scopus, Web of Science, EMBASE,
and Institute of Electrical and Electronics Engineers Digital
Library. The searches were conducted on February 1, 2018. We
additionally hand-searched 5 key electronic journals and 4 gray
literature sources, complemented by Web searches, using the
first 10 page results of 3 engines and thorough screenings of 6
relevant Web pages. Our last research steps consisted of (1) the
manual reference list screening of all eligible studies and (2)
author consultations, requesting input on potentially missed or
unpublished work. A more detailed description of our study
identification strategy is provided in previously published
protocol [21].
The full search strategy and search terms are provided in
Multimedia Appendix 2.
Step 3: Study Selection
A total of 2 members of the research team (VN and PL)
independently conducted a screening of the titles and abstracts,
as well as full text screening against a set of predefined
eligibility criteria (Textbox 1). Not fulfilling all conditions
below led to exclusion.
Textbox 1. Study eligibility criteria.
• Addresses electronic patient-generated health data (PGHD), as defined by this review, and additionally does the following:
• Includes at least one sentence on the electronic PGHD tool or type.
• Includes at least one sentence on how these are used or created.
• Addresses PGHD that are available in a digital format at the point of utilization for intended health-related purposes, irrespective of the
generation process.
• Has a main focus on primary prevention and health promotion and falls within one the following domains:
• Preventing initial occurrence of disease in healthy or high-risk individuals.
• Mitigating risk in healthy or high-risk individuals.
• Promoting existing health.
• Describes, explores, and analyzes some form of health care consumer and provider involvement, where provider can be a technology or a human
provider.
• Addresses an adult population.
• Is a primary study published in English or German between January 1, 2003, and January 31, 2018.
Step 4: Charting the Data
Data extraction was conducted by 2 reviewers (VN and PL),
guided by a predefined, flexible data extraction form, to capture
the review’s objectives and corresponding research questions.
The final form was refined and validated through consultation
and expert feedback. Impact data were broadly extracted in
terms of significance and direction. Equity data were extracted
according to Cochrane Equity Group recommendations [23].
The 2 reviewers (VN and PL) initially tested the form on a
random sample of 5 studies, following immediate comparisons
and adjustments [20,24]. Owing to the large volume of the
included literature, extractions were divided among the 2
reviewers. To minimize subjective bias, 27.3% (50/183) of all
completed data extraction forms were randomly selected for
validation by a third reviewer who added comments and
amendments. Recommended changes were discussed and
integrated with consensus.
Step 5: Collating, Summarizing, and Reporting the
Results
The whole process, including data charting (Step 4), was guided
by an adapted PGHD flow framework, provided in Multimedia
Appendix 3 [6,21]. Our adapted version visualizes the flow of
PGHD from the consumer, passing through intermediaries
(technology or health care provider) and back to the consumer
in the form of prevention and health promotion impact. Initial
synthesis was quantitative, aiming to provide a descriptive
summary of study and participant characteristics, as well as the
extent, scope, and nature of the existing literature. Further
synthesis was qualitative and followed an iterative thematic
approach [20]. Raw data were coded, thematically clustered,
and transformed into conceptual maps that facilitated the
identification of patterns. The entire process, including screening
(Step 3) and data extraction (Step 4), was conducted in
Covidence (Cochrane), a Web-based systematic reviewing tool,
and DistillerSR (Evidence Partners), a multi-functional software
for all types of literature reviews. Reporting is based on the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement [25].
Step 6: Consultation
An external PGHD expert was consulted twice during the
conceptualization stage who provided content-related feedback.
A total of 3 stakeholders, a provider-partner (physician) and 2
consumer-partners, were consulted during the final manuscript
preparation stages to ensure that our interpretations were
relevant and understandable.
Results
Summary
The deduplicated database search resulted in 8556 citations,
which were screened by titles and abstracts. Full-text appraisal
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was deemed eligible for 305 studies, of which 199 did not fulfill
our inclusion criteria. In total, the electronic database searches
yielded 106 included studies. Interrater agreement reached 84%
(42/50) (k=0.411) for a sample of 50 studies during title and
abstract screening and 93% (14/15) (k=0.636) for a sample of
15 studies during full-text review. Complementary searches,
including hand searching and searching gray literature sources,
led to the inclusion of 30 studies, whereas reference list
screenings and author consultations led to 47 additional studies,
resulting in a total of 183 inclusions. A list of all excluded
references at full-text screening, including justifications, is
provided in Multimedia Appendix 4. A list of included studies
and their extracted study characteristics are provided in
Multimedia Appendices 5 and 6, respectively. The PRISMA
flow chart [25] in Figure 1 summarizes the whole study process.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart. PGHD: patient-generated health data.
Study Characteristics
Most eligible studies were published as scientific journal articles
(n=162), followed by sections of conference proceeding
collections (n=13) and published theses (n=8). With an average
of 22 studies per year, most were published from 2011 onward,
whereas the number of publications averaged to around 6 studies
a year between 2003 and 2010. More than half of the studies
were conducted in North America (n=107), with 105 from the
United States and 2 from Canada. European research followed
with 38 studies, most of which were conducted in the United
Kingdom. The remaining were conducted in Australia and New
Zealand (n=18), Asia (n=13), and the Middle East (n=1). A total
of 6 studies had an international scope. Randomized controlled
trials constituted most of the applied methodologies (n=93),
followed by quantitative nonrandomized approaches (n=47),
mixed-method designs (n=30), and purely qualitative
methodologies (n=13). The majority aimed to demonstrate
effectiveness and efficacy (n=99), followed by mixed and purely
exploratory aims (n=52), whereas less than a quarter explored
feasibility and acceptability of interventions (n=32). The
duration of identified studies ranged from a single examination
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to up to 2 years. More detailed information on study
characteristics, including percentages, is provided in Multimedia
Appendix 5. Participant characteristics are summarized in
Multimedia Appendix 7.
Electronic Patient-Generated Health Data—Enabled
Prevention Areas and Aims
The most commonly addressed prevention area was weight
management, primarily in the form of physical activity and
nutrition, which consists of 68.3% (125/183) of the identified
literature. This is followed by 12.0% (22/183) of studies with
a broader focus on health and well-being. These studies did not
exclusively focus on one prevention area and included
combinations of chronic and infectious disease, as well as mental
health. About 7.7% (14/183) of the literature addressed
cardiometabolic health, whereas 7.1% (13/183) focused on
substance use prevention, targeting tobacco and alcohol. Healthy
aging, such as prevention of falls, cognitive decline, and bone
health, was the subject of 6 studies (6/183, 3.3%), followed by
2 studies on breastfeeding (2/183, 1.1%) and 1 study on skin
cancer prevention (1/183, 0.5%). Multimedia Appendix 8
provides a list of included studies grouped by prevention areas.
We continued our analysis by synthesizing information on the
aims of generating and sharing PGHD for primary disease
prevention and health promotion purposes. We identified that
enabling health consumers to generate their own health
information aims at (1) promoting healthy behavior (142/183,
77.5%), (2) increasing health knowledge and self-awareness
(120/183, 65.5%), (3) enabling healthy environments (60/183,
32.7%), and (4) enhancing remote monitoring (20/183, 10.9%).
Most studies (134/183, 73.2%) targeted 2 or more of those aims.
A similar pattern was observed within prevention areas, with
health behavior change and knowledge gain being the most
commonly addressed aims. This was not the case for substance
use prevention, where enabling healthy environments
outweighed knowledge gain. Not all studies adhered strictly to
those aims, with 21.3% (39/183) deviating from purely
preventive purposes and additionally using PGHD as outcome
measures, for example, to quantify the effects of interventions
and for secondary analyses. Table 1 describes the 4 identified
aims and provides examples from the literature.
Table 1. Description and examples of patient-generated health data aims.
Example from the literatureDescriptionAim
Participants record dietary intake and receive weekly
feedback with summaries on their fruit, vegetable, and junk
food intake [26]
Increase in knowledge and cognition about one’s health,
well-being, and behavior, with no particular focus on how
to translate this knowledge into action and concrete behav-
ior
Increase health knowledge
and self-awareness
Participants record dietary intake and receive nutritional
feedback and additional individual dietary targets, recipes,
and a meal plan for achieving those [27]
Help translate one’s knowledge into action, behavior
change, and skill development, targeting health improve-
ment and maintenance
Promote healthy behavior
Participants record physical activity in a digital partnership
with family members or friends, creating an environment
of healthy social pressure and support [28]
Enable environments and contexts that facilitate health and
well-being
Enable healthy environ-
ments
Participants record blood pressure, blood glucose, weight,
and body fat at home and sent data electronically to medical
professional who monitors and provides personalized
physical activity plans [29]
Enable the remote monitoring of individual health and well-
being parameters, by health care and wellness providers
Enhance remote monitoring
The Role of Consumers
Successful prevention undoubtedly requires a clear definition
of health care consumer responsibilities. Our analysis identified
3 broad consumer roles. The first consisted of passive PGHD
generation (20/183, 10.9%), in which consumers used
sensor-based devices to automatically collect and transmit
information. Such an approach was predominantly applied in
physical activity, weight loss, and overall health and well-being,
capturing data that did not require manual entries, such as step
counts, heart rate, and sleep quality. The more common second
and third roles consisted of fully (100/183, 54.6%) or partially
(63/183, 34.4%) active consumers, requiring occasional to
regular actions. Active consumer involvement is key for
capturing data that are not easily captured automatically, such
as consumed meals and the quantity of smoked cigarettes. The
term partially active describes all approaches that involve both
active and passive data generation. That includes anything that
is not exclusively sensor-based, nor exclusively dependent on
manual entries. Partially active data generation was highly
prevalent in prevention areas that often require the simultaneous
collection of multiple heterogenous measures (eg, steps, food
intake, blood pressure and blood glucose), which was the case
in weight loss, physical activity, nutrition, and cardiometabolic
health. Table 2 summarizes consumer roles and provides
illustrative literature examples. Table 3 provides the spread of
consumer roles across identified prevention areas.
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Table 2. Patient-generated health data–related consumer roles and examples.
Examples from the literatureConsumer roles
Data generation roles
Take picture of meal and optionally add descriptions, visit website to add further contextual information
[30]
Fully active data generation
Manually record stress levels and automatically capture data by wearing heart monitor [31]Partially active data generation
Carry mobile phone an physical activity monitor that generates PGHDa automatically [32]Passive data generation
Data sharing roles
PGHD automatically stored on mobile phone based database and automatically transmitted in an encrypted
manner [33]
Low-intensity data sharing
Share data manually from monitors to website (directly or via a docking station) [34-35]High-intensity data sharing
aPGHD: patient-generated health data.
Data generation is often followed by data sharing to third parties
or across devices and storage locations. Information on data
sharing was provided by about 73.2% (134/183) of the literature.
We defined high-intensity sharing as any transmission of PGHD
that requires concrete consumer action. High-intensity sharing
was applied in 91 studies (91/183, 49.7%). Half of those (39/91,
43%) indicated more demanding actions requiring the active
transfer of PGHD to external devices (eg, external computer)
or storage locations (eg, server and website). In contrast,
low-intensity sharing describes the automatic transmission of
PGHD, which was applied in 43 (43/183, 23.5%) studies. We
did not identify any difference of distribution between higher
or lower sharing intensity across most prevention areas, except
for cardiometabolic health and weight loss (Table 3). In
cardiometabolic health, most studies described high-intensity
data sharing. This can be attributed to the frequent use of less
connected devices, such as blood pressure monitors and
glucometers. An opposite trend was observed in weight loss
interventions that tended to adopt low-intensity sharing, which
could be attributable to the sophistication and good
interoperability of fitness trackers. Among the studies
(n=163/183) with fully or partially active consumers, 137
provided clear information on the frequency of PGHD sharing.
Out of those, 110 (110/137, 80.3%) described daily and 27
(27/137, 19.7%) less than daily sharing frequency.
On the basis of the initial framework by Shapiro et al, we
developed an extended and more comprehensive conceptual
framework [6,21]. With consumer roles as a starting point, our
framework visualizes the generation and flow of electronic
PGHD and is adapted to the context of primary disease
prevention and health promotion. The framework, illustrated
in Figure 2, organizes the study’s key results and visualizes
identified patterns.
Our enriched framework shows that the 3 identified consumer
roles are linked to different PGHD tools, ultimately creating
different clusters of data. Although we identified interventions
stopping at that level (single-component), the majority entailed
additional intervention components (multicomponent), with and
without human provider involvement. Thus, prevention and
health promotion impact can be achieved at 3 levels, as the
lower arrows indicate. Across the different elements, from the
consumer to the provider, 5 common areas of barriers and
facilitators can inhibit or promote the effective use of electronic
PGHD. The framework additionally visualizes the link between
identified PGHD aims and additional intervention components,
as well as the involvement of health care providers. This
framework fulfills the function of providing a simplified process
overview, ultimately fostering a better understanding of PGHD
utilization across prevention areas. All framework components
are detailed throughout the results section.
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Table 3. Distribution overview of key themes across prevention areas.
Skin can-
cer (n=1),
n (%)
Breastfeeding
(n=2), n (%)
Healthy aging
(n=6), n (%)
Substance use
(smoking and
alcohol; n=14),
n (%)
Cardio-
metabolic
health (n=14), n
(%)
Overall health
and well-being
(n=21), n (%)
Weight control,
physical activity,
nutrition (n=125),
n (%)
Prevention areas
Consumer roles (data generation)a
1 (100)2 (100)3 (50)14 (100)4 (29)11 (52)65 (52.0)Active data generation
0 (0)0 (0)1 (17)0 (0)9 (64)7 (33)46 (36.8)Partially active data
generation
0 (0)0 (0)2 (33)0 (0)1 (7)3 (15)14 (11.2)Passive data generation
Consumer roles (data sharing)a
1 (100)0 (0)1 (17)4 (29)8 (58)9 (43)43 (34.4)High-intensity data
sharing
0 (0)0 (0)2 (33)4 (29)3 (21)8 (38)51 (40.8)Low-intensity data
sharing
0 (0)2 (100)3 (50)6 (42)3 (21)4 (19)31 (24.8)Unclear or not de-
scribed
Health care provider roles
0 (0)0 (0)0 (0)0 (0)0 (0)3 (14)2 (1.6)Support and motivate
PGHDb
0 (0)1 (50)1 (17)3 (21)5 (36)1 (5)23 (18.4)Review and analyze
PGHD
0 (0)0 (0)0 (0)1 (7)4 (29)0 (0)12 (9.6)Support and Motivate
PGHD and review and
analyze PGHD com-
bined
0 (0)0 (0)0 (0)0 (0)1 (7)2 (10)14 (11.2)Non-PGHD-related in-
volvement
1 (100)1 (50)5 (83)10 (72)4 (28)15 (71)74 (59.2)No involvement at all
Utilized hardwarec
1 (100)2 (100)5 (83)14 (100)12 (86)18 (86)104 (83.2)Nonhealth-related (eg,
phone)
0 (0)0 (0)2 (33)0 (0)10 (71)12 (87)65 (52.0)Health-related (eg, pe-
dometer)
0 (0)0 (0)0 (0)5 (36)5 (36)3 (14)2 (1.6)Medical (eg, glucome-
ter)
Additional intervention componentsa,c
0 (0)2 (100)5 (83)11 (79)13 (93)16 (76)113 (90.4)Reflective
1 (100)1 (50)5 (83)12 (86)13 (93)9 (43)99 (79.2)Process guiding
1 (100)0 (0)4 (67)13 (93)7 (50)8 (38)88 (70.4)Motivational
0 (0)2 (100)2 (33)10 (71)10 (71)6 (29)84 (67.2)Educational
aConsumer roles are described in patient-generated health data–related consumer roles and examples table. Additional intervention components are
defined in detail in descriptions of intervention components.
bPGHD: patient-generated health data.
cStudies were assigned to multiple hardware and additional intervention component categories, for which rows do not add up to 100%.
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Figure 2. Enriched conceptual framework of electronic patient-generated health data (PGHD) flow and use for primary disease prevention and health
promotion.
Electronic Patient-Generated Health Data Tools, Their
Functions, and Data Types
Prevention-targeted PGHD were generated through 3 broad
types of hardware, often used in combination. The first included
nonhealth-related products that are mostly well integrated into
daily living (157/183, 85.8%), such as computers and mobile
phones. The second entailed health-related devices that are less
societally integrated (90/183, 49.2%), such as pedometers and
heart rate monitors. The third included more specialized medical
devices (15/183, 8.2%), such as glucometers and blood pressure
monitors. Beyond manual and automatic PGHD collection, their
most common functions included the provision of additional
intervention components, such as goal setting and reminders,
analysis and visualization of data, provision of feedback, sharing
and storage of PGHD, and communication and interaction with
third parties. Another key function was the provision of cues
and visualizations, such as using color schemes, pictures,
avatars, and other virtual elements to support the interpretation
of PGHD. Table 3 provides the distribution of utilized hardware
across prevention areas. Multimedia Appendix 9 offers more
detailed information on identified tools and their functions.
Most studies (175/183, 95.6%) have additionally described the
use of software, such as apps, mobile- and Web-based programs,
Web-based platforms and websites, social media and forums,
device-installed software, and email and text messaging. The
remaining 4.4% (8/183) did not explicitly mention any utilized
software.
The identified electronic PGHD were categorized in 4 broad
types. Most studies (78/183, 42.6%) addressed textual or
numerical data, requiring manual entry and an active consumer.
This was followed by waves or signals (22/183, 12.0%) that
did not require manual collection and audiovisual (video) (4/183,
2.2%) as well as photographic (2/183, 1.1%) PGHD, which
again required an active user. Textual or numerical data were
mostly used in weight control, substance use prevention, and
healthy aging. Photographic data were applied in healthy eating,
whereas audiovisual PGHD were commonly utilized in smoking
and alcohol prevention. Waves and signals were primarily
applied in weight control, well-being, cardiometabolic health,
and healthy aging. Finally, almost half of the studies used 2 or
more forms of digital PGHD (77/183, 42.1%), with the most
common combinations being that of textual or numerical with
waves or signals (58/77, 75%) and textual or numerical with
photographic data (7/77, 9%). Textual or numerical with waves
or signals was used across the spectrum of health domains from
weight control to diabetes prevention and usually included initial
sensor data that were then manually recorded by users. Textual
or numerical with photographic data was applied in dietary
interventions, where users took pictures of their meals and added
descriptions.
Electronic Patient-Generated Health Data Use:
Additional Intervention Components
In 172 (172/183, 93.9%) of the identified studies, PGHD were
embedded in larger multicomponent preventive interventions.
Our analysis identified 4 overarching components to which
PGHD were combined with, categorized as (1) reflective, (2)
process guiding, (3) motivational, and (4) educational. Their
descriptions and examples are provided in Textbox 2. Most
interventions entailed at least one (162/183, 88.5%) purely
reflective component, whereas 77.6% (142/183) included at
least one process guiding component. Motivational components
were included in 67.2% (123/183) of all interventions, with
social support (eg, online peer interaction) constituting 33.3%
(61/183) of those. Finally, educational components were
identified in 63.4% (116/183) of all studies. A distinct element
of educational components was the provision of support for
making sense of one’s health data, through a-priori training or
instructions, as well as targeted immediate or retrospective
feedback. Table 3 provides the distribution of additional
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intervention components across prevention areas. The
boundaries between those 4 components were not fixed, and
each study was often assigned to more than 1 category. Most
of these components (147/172, 85.5%) were entirely or partially
tailored to individual participants, whereas a relatively smaller
proportion (25/172, 14.5%) were predominantly nontailored or
unclear. The overlap between identified aims for collecting
PGHD and additional interventions components (eg, educational
components and the aim of knowledge enhancement,
motivational components, and aim of behavior change)
suggested that underlying reasons for generating and using
PGHD for preventive purposes might influence and be
influenced by the availability of these additional intervention
components. Additional intervention components are defined
in detail in Textbox 2.
Textbox 2. Descriptions of intervention components.
1. Reflective: All intervention components that are based on simple feedback of generated patient-generated health data (PGHD), with no additional
educational information on how these are to be interpreted and applied. Examples include PGHD reports and summaries, as well as access to
unstructured data.
2. Process guiding: All intervention components that aim to provide general support on the generation of PGHD, the use of technology, the compliance
to intervention guidelines, and the response to problems arising from these processes. They include technical advice, instructions on when and
how to collect and share, and problem-solving advice. Guidance in understanding and applying PGHD falls out this category’s scope (see point
4. Educational).
3. Motivational: All intervention components that are based on techniques that target the motivation of users to collect PGHD and apply those for
healthy behavior changes. They include the provision of rewards and incentives, persuasion techniques, goal setting, reminders, motivational
feedback, social support, as well as entertainment elements, such as gamification.
4. Educational: All intervention components that go beyond the simple feedback of generated PGHD (reflective), being attached to additional
information that targets knowledge and skill enhancement, as well as knowledge testing. In contrast with process guiding, this category focuses
on understanding and applying PGHD. They include the provision of newsletters, in-person counseling, remote coaching, educational podcasts,
quizzes, and knowledge tests. Technical guidance on the generation and share of PGHD falls out of this category’s scope (see point 2. Process
guiding).
The integration and utilization of electronic PGHD varied across
additional intervention components. In combination with
reflective components, PGHD were mostly used for
self-referencing, such as the visualization of progress over time,
enabling users to track individual health goals. In the context
of motivational components, PGHD were repeatedly utilized
to enable social comparison, such as contrasting data to
normative or peer-generated values, often generating certain
social pressure for healthier lifestyles. When integrated with
educational components, PGHD were used to inform and
provide individualized recommendations and counseling, aligned
to the progress and capabilities of individual participants or
participant subgroups. Finally, in combination with process
guiding components, PGHD were key to identifying individual
challenges, allowing for tailored and problem-focused support,
while ensuring that adherence to intervention guidelines (eg,
dietary or exercise plans) was monitored.
The Role of Health Care Providers
Less than half of the literature described the role of health care
providers in the implementation (73/183, 39.9%) of interventions
and only 30.6% (56/183) involved providers that had clearly
designated PGHD-related responsibilities. The remaining
proportion of the literature (110/183, 60.1%) addressed
predominantly automatic programs. The proportion of studies
without provider involvement was larger across all prevention
areas, except for those on cardiometabolic health and
breastfeeding promotion. Health care providers included an
array of professionals, including physicians, nurses, dieticians,
psychologists, health consultants, fitness experts, and trainers.
Our thematic analysis identified 2 main clusters of
PGHD-related provider roles. The first role (5/55, 9%) is that
of a supporter, including the prompting, overseeing, and
motivating of PGHD use, which was primarily found in weight
control, nutrition and well-being interventions. The second role
(34/55, 62%) is that of a reviewer, consisting of analyzing
PGHD to inform counseling, personalize advise, conduct remote
monitoring, and complement medical data, which was common
in weight control, nutrition, cardiometabolic health, and
substance use prevention. In 31% (17/55) of the studies, mainly
in weight control, cardiometabolic health, and substance use
prevention, providers held both roles simultaneously. In
addition, we identified that provider-consumer interactions
predominantly occurred remotely (36/73, 49%), either via the
PGHD tool itself (eg, data collection website) or through other
supporting channels (eg, email), both in a synchronous (eg,
telephone) or asynchronous fashion (eg, forums). In-person
interactions were less common (14/73, 19%) and more often
combined with remote elements (17/73, 23%). One study (1/73,
1%) involved no direct interaction with consumers, whereas 5
(5/73, 7%) lacked clear interaction descriptions. Our findings
additionally suggested that the involvement of health care
providers was linked to the previously described PGHD aims,
as one of those, namely the aim of enhanced remote monitoring,
inevitably relies on data review by a provider. Table 3 provides
the distribution of provider roles across prevention areas.
Patient-Generated Health Data Implications: Health
Impact and Equity
Assessed prevention-relevant outcomes were broadly
categorized into: (1) vitals and body composition measures (eg,
body mass index, blood pressure, blood glucose, and heart rate),
(2) behavioral change (eg, physical activity, eating habits, and
lifestyle factors), and (3) knowledge change (eg, health literacy
and awareness). About a quarter of the identified literature
(47/183, 25.7%) provided indications on the potential impact
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of PGHD on preventive outcomes. These studies either had
PGHD as a distinct or single component in one of their
intervention arms (13/47, 28%), or as a part of multicomponent
interventions (34/47, 72%), with sections that explored the
associations between PGHD (eg, adherence to data collection)
and outcomes. The majority explored implications on vitals and
body composition-related outcomes (37/47, 79%). Most of those
studies reported statistically significant beneficial trends (n=27),
followed by nonsignificant effects (n=8) and mixed results
(n=4). Outcomes in health behavior were less commonly
addressed (15/47, 32%) and provided no clear tendencies, with
an equal number of studies providing statistically significant
beneficial (n=4) and nonsignificant (n=4) trends, as well as a
relatively large proportion of unclear or mixed results (n=3).
Health knowledge outcomes were the least commonly (2/47,
4%) addressed, with one study reporting nonsignificant
associations between PGHD and health knowledge and one
reporting mixed results. Most of these studies included active
(27/47, 57%) and partially active consumers (8/47, 17%),
whereas only one study entailed passive consumers (1/47, 2%).
For the studies with active and partially active user engagement,
a proportionally equal number of them reported statistically
significant, mixed, and nonstatistically significant results. One
study that included passive consumers did not provide enough
information to be meaningfully compared.
A larger proportion of the literature (98/183, 53.6%) addressed
interventions with multiple components and did not entail
analyses on the relationship between PGHD components and
prevention outcomes. Although their results could not be directly
linked to PGHD, the overall picture suggested beneficial trends,
with 23% (22/98) providing almost entirely positive results.
Mixed results were indicated by 69% (68/98) of studies, almost
all of which included at least one significantly positive outcome.
A smaller proportion of interventions (8/96, 8%) did not identify
beneficial effects at all. The remaining part of the literature
(38/183, 20.8%) focused on feasibility and usability results
instead, which is not reported in further detail here.
Considering equity as an important outcome for all health
interventions, we extracted information linked to implications
for subgroups that are commonly divided by health inequalities,
as defined by the Cochrane Equity Group [23]. About 46.5%
of studies (85/183) addressed equity by referring to the digital
divide and literacy inequalities, by addressing the limitations
of homogeneous study samples that primarily consisted of
advantaged subgroups (eg, white, highly educated), by focusing
on underserved populations, and by exploring patterns across
sociodemographic variables. Approximately 7.7% of the
literature (14/183) provided detailed analyses across subgroups
divided by sex (12/14), age (6/14), race (4/14), education (4/14),
income (2/14), and place of residence (1/14). Most of those
indicated either no or unclear differential effects, whereas 2
indicated better intervention effects for younger participants,
one for white non-Hispanic individuals and one for higher
educated participants.
Barriers and Facilitators of Electronic
Patient-Generated Health Data Use
About 89.6% (164/183) of studies provided information on
potential barriers and facilitators of electronic PGHD. Both
barriers and facilitators were clustered around 5 recurring
themes: (1) data collection and use, (2) technical and design
considerations, (3) ethics, safety, and trust, (4) user
characteristics, and (5) context and content. Data collection and
use (127/164, 77.4%) addressed the levels of ease, difficulty,
and burden of electronic PGHD generation, the adaptability of
data collection to user needs, and associated resource demands
(eg, time, costs). Technicalities and design (84/164, 51.2%)
covered the functional maturity of PGHD technology, the
facilitating role of mobile and interoperable devices, as well as
the importance of dynamic, user-appealing, and simple designs.
Ethics, safety, and trust (55/164, 33.5%) entailed barriers and
facilitators around privacy, trustworthiness, credibility, and
reliability. The category of user characteristics (72/164, 43.9%)
highlighted consumer-related elements, such as digital literacy,
knowledge, sociodemographic determinants, and overall
attitudes toward PGHD technologies. Finally, the last category
of content and context (148/164, 90.2%) included elements
around contextual resources, such as PGHD support and
interaction with providers. It additionally addressed the role of
technology and intervention content, such as the combination
of PGHD with other behavior change communication
techniques. Textboxes 3 and 4 provide a list of identified barriers
and facilitators across those 5 themes.
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Textbox 3. Barriers of electronic patient-generated health data and the number of studies reporting barriers in each domain.
Data collection and use (n=49):
• Burdensome data collection
• Inflexible data entry
• Retrospective data entry: incentive to manipulate data
• Unstructured data: information overload
• Automatized recording: feeling of no control over data
• Costly
Technicalities and design (n=39):
• Immature or nonfunctional
• Unappealing design
• Nonuser-friendly functions
Ethics, safety, and trust (n=32):
• Privacy and security concerns
• Nontrustworthy patient-generated health data (PGHD) tools and data
• Sociocultural resistances
• Low-quality and unreliable PGHD
User characteristics (n=38):
• Low digital literacy and no previous experience
• Negative attitudes toward PGHD
• Mismatch with daily life routines
• Nonperceived usefulness
• Sociodemographics (eg, young age, low education)
Content and context (n=44):
• Missing data interpretation and general support
• Missing in-person contact
• Missing or too frequent reminders
• Missing provider resources to evaluate PGHD
• Missing (financial) incentives or rewards
• Missing or insensitive feedback
• Unrealistic goals
• Nonengaging environment (eg, no social support)
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Textbox 4. Facilitators of electronic patient-generated health data and the number of studies reporting facilitators in each domain.
Data collection and use (n=78):
• Simple and low-effort data collection
• Highly flexible data entry
• Retrospective data entry: incentive to correct data
• Time-efficient and intuitive data output
• Automatized recording: noninterference with daily life
• Free or low cost
Technicalities and design (n=45):
• Technically mature and interoperable
• User-engaging and appealing design
• Dynamic design: interactive and modifiable
• Mobile
Ethics, safety, and trust (n=23):
• Credible patient-generated health data (PGHD) tools
• Trustworthy, reliable, and complete PGHD
• Processes that do not invade privacy
User characteristics (n=34):
• Digital literacy and previous experience
• Preexisting motivation and readiness to use PGHD
• Self-efficacy
• Perceived PGHD usefulness and relevance
Content and context (n=104):
• Available guidance and support
• Available human interaction
• Sensitive reminders that do not disturb
• Data visualizations and summaries
• Motivating rewards and (financial) incentives
• Immediate, sensitive, and motivating feedback
• Realistic goal setting
• Social support (eg, peer interactions)
• Content and context personalization
• Enabled data access, ownership, and control
• Fun elements (eg, gamification)
• Novel elements (eg, geofence triggered support)
Discussion
Overview
Our review described a large and dynamically emerging volume
of the literature on the use of electronic PGHD for primary
disease prevention and health promotion purposes. Beyond
quantity, the literature manifested large methodological and
thematic heterogeneity, adding to the topic’s conceptual
complexity. Our results enabled the development of an enriched
conceptual framework (Figure 2) and thus a better understanding
of the process between generating PGHD and finally utilizing
them for preventive and health promoting action.
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Principal Findings and Comparison With Previous
Work
The identified literature predominantly focused on weight
control, through physical activity and nutrition, which was
consistent with previous reviews that addressed digital health
interventions across prevention areas [36-38]. In line with the
variety of existing digital approaches to primary disease
prevention [39-40], our results indicated that electronic PGHD
target multiple dimensions, including: (1) health knowledge
and self-awareness, (2) behavior change, (3) healthy
environments, and (4) remote monitoring. Overall, we identified
4 types of prevention-targeted interventions entailing electronic
PGHD: (1) automatic, single component, (2) automatic
multicomponent interventions, (3) single component, and (4)
multicomponent interventions that are not fully automatic,
including health care provider involvement (Figure 2). A single
component denotes that PGHD is the main and only prevention
element, whereas a multicomponent describes interventions
with at least 1 additional non-PGHD element.
Our thematic analysis identified certain recurring patterns of
PGHD generation. We broadly classified consumer roles as
passive, partially active, and fully active and identified that the
proportions of these vary across prevention areas.
Acknowledging that consumer roles are closely linked to PGHD
types, we found that certain prevention areas are being
dominated by 1 or 2 types of PGHD. On one hand, weight
control, alcohol and smoking prevention, and overall health and
well-being seemed to be mostly addressed by technologies that
require the manual collection of textual or numerical data, while
on the other hand, cardiometabolic disease prevention was
primarily addressed by a combination of PGHD types that
require a mix of active and passive data generation. In contrast,
entirely passive data generation was only identified for weight
control, overall health and well-being, cardiometabolic health,
and healthy aging. Although not focused on prevention, a review
by Vagesna et al [41] identified similar patterns, where weight
was monitored by computerized systems (manual data entry)
and metabolic conditions by a combination of multiple
technologies.
Considering that the sophistication and reliability of PGHD
technology varies across prevention areas, these patterns are
expected. To be adequately targeted and well-informed,
prevention often requires very specific consumer action and
PGHD input. On one hand, for certain areas, such as addiction
prevention or dietary intake, this input is entirely behavioral
and not easily captured automatically. This includes the exact
number of smoked cigarettes and consumed alcohol drinks, the
type of consumed drinks, the percentage of alcohol content in
each drink or the portions of consumed meals, all of which
currently cannot be reliably or cost effectively collected by
sensor-based devices, while on the other hand, sophisticated
and highly commercialized fitness trackers are increasingly
being improved to reliably capture certain activities and bodily
functions, such as physical exercise and heart rate.
Exercise-based weight loss, well-being promotion (eg, sleep
quality), and healthy aging (eg, fall prevention) are prevention
areas in which such devices can be applied to, which explains
the prevalence of passive PGHD generation. In between the two
extremes, there are prevention approaches that inherently require
combinations of measures, such as in diabetes prevention (eg,
dietary intake and physical activity), which in turn allow for a
partially active and partially passive generation of PGHD.
Linking consumer roles to identified barriers and facilitators
suggests some conflicting dynamics. Passive PGHD generation
might be less burdensome, but may also lead to lower consumer
engagement. Conversely, active generation involves more effort
but may simultaneously trigger higher user motivation. In their
review on wearable monitoring technology, Baig et al [42]
described part of these challenges, such as that passive
application of technology might counteract user engagement
and acceptance. Another review linked the intensity of consumer
responsibilities to intervention effectiveness, reporting that
programs with active consumers (eg, manual data input) were
more successful [43]. To fully understand the most effective
use of electronic PGHD for prevention, these patterns suggest
that is important to further explore the interactions between
PGHD types and their demands on consumers.
The relatively large proportion of studies that described
automatic prevention systems, constituting 60.1% (110/183) of
the identified literature, underlines a broader trend toward
low-recourse and efficiency-driven care [44]. As expected, this
was not the case for areas that traditionally rely on close
patient-provider relationships, such as cardiometabolic health
and breastfeeding. The remaining 39.9% (73/183) of the
literature indicated 2 main health care provider clusters: (1)
supporting PGHD collection and subsequently, (2) reviewing
or using data for preventive practice. If fully automatized, those
tasks were transferred to consumers, or the technology itself.
A scoping review on the preventive use of smart devices by
Petit and Cambon [45] described consumer responsibilities as
a key literature aspect, in which patients gained expert roles and
became equal agents of their own health care. Interalia, this has
potential implications on data interpretation that we have
identified as a recurring concept across studies. Previous
research demonstrated the importance of PGHD interpretation
and its wider implications [46], with missing sense-making
skills and the fear of self-interpretation mentioned as key
challenges to personal health information use. Our findings
reflected that importance, as a major proportion of the literature
directly or indirectly addressed interpretability by describing
various approaches to fostering correct data understanding.
Most identified studies integrated electronic PGHD within
multicomponent interventions, either complementing or
facilitating other intervention components (eg, enabling
self-reflection, facilitating social comparison, informing
counseling, and directing guidance). A systematic review on
the use of technology for weight reduction identified a similar
trend, with 19 out of 27 studies combining PGHD with
counseling feedback [47]. These trends highlight the value of
PGHD for complex digital prevention, especially when not
entailing health care providers. In addition, a previous scoping
review by Lentferink et al identified that using PGHD to
personalize intervention components (eg, goal setting) seemed
to be a distinct element of highly effective studies [43].
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Summarizing the results of single-component interventions,
exploratory analyses (eg, associations between PGHD and health
outcomes), and overall effects of multicomponent interventions,
the overall directions suggest a predominantly positive PGHD
impact on prevention. These trends are expected, considering
the existing evidence on the association between monitoring
one’s own health and preventive outcomes [48-50]. On the
contrary, trends on the impact of PGHD on health inequity gaps
were not as clear, as only 7.7% (14/183) of the literature reported
on differential effects across subgroups. The limited information
and methodological ambiguity around subgroup analyses [51]
did not allow for confident equity statements. Equity reviews
from other fields, such as population and primary-care-based
physical activity interventions reported on similar challenges,
with only 19% (17/87) and 14.0% (24/171) of primary studies
providing information on differential distribution of effects
[52,53]. This is problematic, considering the potential
implications of the digital divide, which is transforming from
a divide on technology access to a divide on digital literacy and
skills [54]. If we fail to adequately address equity, we risk
limiting the preventive benefits of technology to those few who
have the resources and skills to use them appropriately.
Nonetheless, it is encouraging that almost half of the literature
directly or indirectly mentioned equity, which indicates that
many researchers are aware of the importance of ethics in digital
health research.
Finally, the existence of conflicting barriers and facilitators
highlighted the currently emerging nature and potential
knowledge gaps of the topic. When do reminders become
disturbances in one’s daily life and when are they the key to
ensuring prevention adherence? Are automatic and simple data
collection methods preferred by consumers because of being
less burdensome, or do they counteract user engagement and
motivation? Do financial rewards act purely as incentives to
collect data and adhere to preventive guidelines, or could they
become incentives for data falsification? Are PGHD tools that
allow for retrospective data entries beneficial because of added
flexibility, or do they add to the risk of data manipulation?
Although these uncertainties may be indicators of an emerging
topic that requires more research, they might also be the result
of electronic health and prevention complexity. Neither
digitalization nor prevention are static or fixed phenomena [55].
They ultimately depend on interactions and contexts, for which
single answers may be difficult to find. Nonetheless, the richness
and range of identified barriers and facilitators indicate that the
preventive use of electronic PGHD is sensitive to many factors,
be it the way data are collected, the context in which they are
collected, the personal characteristics of users, as well as ethical
and technological considerations.
Limitations
Despite our rigorous methodological approach, our study is
subjected to some limitations. First, although PGHD may be
key throughout the continuum of care, our review’s scope is
restricted to primary disease prevention and health promotion.
As such, our overall findings might not be applicable to the
domains of treatment, disease management, and rehabilitation.
This scope is narrower than defined in our protocol and has
been chosen for practical and conceptual reasons. Retaining a
broader scope would have led to an unmanageable volume of
the literature and challenges in meaningfully synthesizing the
results. Second, the chosen definition of electronic PGHD,
which emphasized the aspect of patient’s control, led to the
exclusion of standardized and more provider-driven approaches.
Broadening the definition might provide a better understanding
of PGHD-based prevention within health care contexts and the
interaction of such data streams with health care provider
infrastructures. Third, the variety and evolvement of definitions
and terms to describe PGHD, as well as prevention, might have
led to missing out a few terms and the associated literature. To
compensate for that, we conducted thorough hand searches,
reference list screenings, and author consultations. Finally, our
scoping methodology and heterogeneous output did not allow
for robust synthesis and comparison of effects.
Implications and Future Research
Overall Implications
The patterns we identified may support users, patients, and
providers in understanding the complexity of utilizing electronic
PGHD for prevention purposes. Beyond technical maturity,
providers need to consider the wider implications that data
collection might have on patients and consumers, such as its
interference with daily living, personal beliefs, and digital
literacy. Users and providers need to be sensitive to ethical and
trust concerns, while ensuring that the PGHD environments are
motivating and supportive enough to facilitate adherence and
successful prevention.
Future Research
Scoping reviews are often conducted to assess the feasibility of
conducting a full systematic review [19]. On the basis of the
large and very heterogeneous literature volume, we believe that
conducting a full systematic review, while retaining a similarly
broad scope, will be conceptually difficult. We, therefore,
suggest (1) a narrower scope, (2) a careful a priori consideration
of a PGHD definition, as that differed across the literature and
may impact the review’s results, (3) a careful selection of search
terms, and (4) a preparatory literature scan to identify all terms
appropriate to the chosen scope, as the terminology is vast and
evolving. Beyond systematic reviews, future research should
target evidence on best possible combinations of electronic
PGHD with other behavioral change techniques (eg, feedback,
goal setting, and peer interaction). Finally, future research should
aim to capture how barriers and facilitators vary across contexts,
while addressing the wider implications of PGHD-based
prevention on the functioning of health systems and health
equity.
Conclusions
Our review provides a comprehensive picture of the literature
on electronic PGHD use for primary disease prevention and
health promotion purposes, enabling a broader identification of
processes and patterns. The high heterogeneity in the scope and
content of identified studies underlines the topic’s emerging
nature. This is reflected by the variety of identified
PGHD-generating technologies, resulting in diverse data types
and different consumer responsibilities. Utilizing electronic
PGHD to prevent disease and promote health is a complex
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matter. In the literature, this complexity arises from electronic
PGHD being mostly integrated into multicomponent and
automatized interventions, limiting our ability to assess their
individual preventive impact, and underlining an overall trend
toward larger consumer responsibility. The broad set of
identified barriers and facilitators, some being conflicting,
highlights the need for a holistic understanding of such enabling
factors, as well as for a stronger focus on ethical challenges,
which is currently lacking.
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